EFFECT OF PHARMACEUTICAL INTERVENTION IN PHARMACOLOGICALLY TREATED HYPERTENSIVE PATIENTS. CLUSTER-RANDOMISED CLINICAL TRIAL.

Phase 4

Active, not recruiting

• Conditions: Patients diagnosed with and pharmacologically treated for essential Arterial hypertension; arterial hypertension; community pharmacy care program; health results; pharmaceutical intervention; blood pressure control

• Registration Number: TCTR20190313004
• Lead Sponsor: The Phcare Foundation Institution received PFIZER payments for 2 AMBP devices, and courses to pharma

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2015-06-30
• Study Start: 2019-03-13
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 480

Inclusion Criteria

Patients diagnosed with and pharmacologically treated for essential AHT, who were literate, in full possession of their mental faculties and willing to be monitored for 6 months, were included

Exclusion Criteria

Patients with arrythmia or secondary AHT or who were pregnant were excluded

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
arterial hypertension 6 months community pharmaceutical care intervention

Secondary Outcome Measures

Name	Time	Method
/A N/A N/A